<?xml version='1.0' encoding='utf-8'?>
<document id="24692216"><sentence text="Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat."><entity charOffset="0-7" id="DDI-PubMed.24692216.s1.e0" text="Aspirin" /><entity charOffset="12-22" id="DDI-PubMed.24692216.s1.e1" text="probenecid" /><entity charOffset="84-94" id="DDI-PubMed.24692216.s1.e2" text="cilostazol" /><entity charOffset="99-109" id="DDI-PubMed.24692216.s1.e3" text="probenecid" /><entity charOffset="132-142" id="DDI-PubMed.24692216.s1.e4" text="cilostazol" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e0" e2="DDI-PubMed.24692216.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e0" e2="DDI-PubMed.24692216.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e0" e2="DDI-PubMed.24692216.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e0" e2="DDI-PubMed.24692216.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e0" e2="DDI-PubMed.24692216.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e1" e2="DDI-PubMed.24692216.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e1" e2="DDI-PubMed.24692216.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e1" e2="DDI-PubMed.24692216.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e1" e2="DDI-PubMed.24692216.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e2" e2="DDI-PubMed.24692216.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e2" e2="DDI-PubMed.24692216.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e2" e2="DDI-PubMed.24692216.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e3" e2="DDI-PubMed.24692216.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s1.e3" e2="DDI-PubMed.24692216.s1.e4" /></sentence><sentence text="This study aimed to evaluate the transporter-mediated renal excretion mechanism for cilostazol and to characterize the mechanism of drug-drug interaction (DDI) between cilostazol and aspirin or probenecid"><entity charOffset="84-94" id="DDI-PubMed.24692216.s2.e0" text="cilostazol" /><entity charOffset="168-178" id="DDI-PubMed.24692216.s2.e1" text="cilostazol" /><entity charOffset="183-190" id="DDI-PubMed.24692216.s2.e2" text="aspirin" /><entity charOffset="194-204" id="DDI-PubMed.24692216.s2.e3" text="probenecid" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e0" e2="DDI-PubMed.24692216.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e0" e2="DDI-PubMed.24692216.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e0" e2="DDI-PubMed.24692216.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e0" e2="DDI-PubMed.24692216.s2.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e1" e2="DDI-PubMed.24692216.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e1" e2="DDI-PubMed.24692216.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e1" e2="DDI-PubMed.24692216.s2.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e2" e2="DDI-PubMed.24692216.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s2.e2" e2="DDI-PubMed.24692216.s2.e3" /></sentence><sentence text=" Concentrations of cilostazol and its metabolites OPC-13015 [6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone] and OPC-13213 [3,4-dihydro-6-[4-[1-(trans-4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2-(1H)-quinolinone] in rat biologic or cell samples were measured by liquid chromatography-tandem mass spectrometry"><entity charOffset="19-29" id="DDI-PubMed.24692216.s3.e0" text="cilostazol" /><entity charOffset="128-231" id="DDI-PubMed.24692216.s3.e1" text="OPC-13213 [3,4-dihydro-6-[4-[1-(trans-4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2-(1H)-quinolinone]" /><pair ddi="false" e1="DDI-PubMed.24692216.s3.e0" e2="DDI-PubMed.24692216.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s3.e0" e2="DDI-PubMed.24692216.s3.e1" /></sentence><sentence text=" Coadministration with probenecid, benzylpenicillin, or aspirin decreased the cumulative urinary excretion of cilostazol and renal clearance"><entity charOffset="23-33" id="DDI-PubMed.24692216.s4.e0" text="probenecid" /><entity charOffset="35-51" id="DDI-PubMed.24692216.s4.e1" text="benzylpenicillin" /><entity charOffset="56-63" id="DDI-PubMed.24692216.s4.e2" text="aspirin" /><entity charOffset="110-120" id="DDI-PubMed.24692216.s4.e3" text="cilostazol" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e0" e2="DDI-PubMed.24692216.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e0" e2="DDI-PubMed.24692216.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e0" e2="DDI-PubMed.24692216.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e0" e2="DDI-PubMed.24692216.s4.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e1" e2="DDI-PubMed.24692216.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e1" e2="DDI-PubMed.24692216.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e1" e2="DDI-PubMed.24692216.s4.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e2" e2="DDI-PubMed.24692216.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s4.e2" e2="DDI-PubMed.24692216.s4.e3" /></sentence><sentence text=" Concentrations of cilostazol and OPC-13213 in plasma decreased, and the concentration of OPC-13015 increased in the presence of probenecid"><entity charOffset="19-29" id="DDI-PubMed.24692216.s5.e0" text="cilostazol" /><entity charOffset="34-43" id="DDI-PubMed.24692216.s5.e1" text="OPC-13213" /><entity charOffset="129-139" id="DDI-PubMed.24692216.s5.e2" text="probenecid" /><pair ddi="false" e1="DDI-PubMed.24692216.s5.e0" e2="DDI-PubMed.24692216.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s5.e0" e2="DDI-PubMed.24692216.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s5.e0" e2="DDI-PubMed.24692216.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s5.e1" e2="DDI-PubMed.24692216.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s5.e1" e2="DDI-PubMed.24692216.s5.e2" /></sentence><sentence text=" By contrast, rat plasma cilostazol, in combination with benzylpenicillin or aspirin, sharply increased, and concentrations of OPC-13015 and OPC-13213 did not change"><entity charOffset="25-35" id="DDI-PubMed.24692216.s6.e0" text="cilostazol" /><entity charOffset="57-73" id="DDI-PubMed.24692216.s6.e1" text="benzylpenicillin" /><entity charOffset="77-84" id="DDI-PubMed.24692216.s6.e2" text="aspirin" /><entity charOffset="127-136" id="DDI-PubMed.24692216.s6.e3" text="OPC-13015" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e0" e2="DDI-PubMed.24692216.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e0" e2="DDI-PubMed.24692216.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e0" e2="DDI-PubMed.24692216.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e0" e2="DDI-PubMed.24692216.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e1" e2="DDI-PubMed.24692216.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e1" e2="DDI-PubMed.24692216.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e1" e2="DDI-PubMed.24692216.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e2" e2="DDI-PubMed.24692216.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s6.e2" e2="DDI-PubMed.24692216.s6.e3" /></sentence><sentence text=" In urine, OPC-13015 was below the level of detection" /><sentence text=" The cumulative urinary excretion of OPC-13213 decreased in the presence of probenecid, benzylpenicillin, or aspirin"><entity charOffset="76-86" id="DDI-PubMed.24692216.s8.e0" text="probenecid" /><entity charOffset="88-104" id="DDI-PubMed.24692216.s8.e1" text="benzylpenicillin" /><entity charOffset="109-116" id="DDI-PubMed.24692216.s8.e2" text="aspirin" /><pair ddi="false" e1="DDI-PubMed.24692216.s8.e0" e2="DDI-PubMed.24692216.s8.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s8.e0" e2="DDI-PubMed.24692216.s8.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s8.e0" e2="DDI-PubMed.24692216.s8.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s8.e1" e2="DDI-PubMed.24692216.s8.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s8.e1" e2="DDI-PubMed.24692216.s8.e2" /></sentence><sentence text=" Cilostazol was distributed in the kidney and liver, with tissue to plasma partition coefficient (Kp) values of 8"><entity charOffset="1-11" id="DDI-PubMed.24692216.s9.e0" text="Cilostazol" /></sentence><sentence text="4 ml/g and 16" /><sentence text="3 ml/g, respectively" /><sentence text=" Probenecid and aspirin reduced cilostazol distribution in the kidney"><entity charOffset="1-11" id="DDI-PubMed.24692216.s12.e0" text="Probenecid" /><entity charOffset="16-23" id="DDI-PubMed.24692216.s12.e1" text="aspirin" /><entity charOffset="32-42" id="DDI-PubMed.24692216.s12.e2" text="cilostazol" /><pair ddi="false" e1="DDI-PubMed.24692216.s12.e0" e2="DDI-PubMed.24692216.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s12.e0" e2="DDI-PubMed.24692216.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s12.e0" e2="DDI-PubMed.24692216.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s12.e1" e2="DDI-PubMed.24692216.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s12.e1" e2="DDI-PubMed.24692216.s12.e2" /></sentence><sentence text=" Probenecid did not affect cilostazol metabolism in the kidney but increased cilostazol metabolism in the liver, and aspirin had no effect on cilostazol metabolism"><entity charOffset="1-11" id="DDI-PubMed.24692216.s13.e0" text="Probenecid" /><entity charOffset="27-37" id="DDI-PubMed.24692216.s13.e1" text="cilostazol" /><entity charOffset="77-87" id="DDI-PubMed.24692216.s13.e2" text="cilostazol" /><entity charOffset="117-124" id="DDI-PubMed.24692216.s13.e3" text="aspirin" /><entity charOffset="142-152" id="DDI-PubMed.24692216.s13.e4" text="cilostazol" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e0" e2="DDI-PubMed.24692216.s13.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e0" e2="DDI-PubMed.24692216.s13.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e0" e2="DDI-PubMed.24692216.s13.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e0" e2="DDI-PubMed.24692216.s13.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e0" e2="DDI-PubMed.24692216.s13.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e1" e2="DDI-PubMed.24692216.s13.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e1" e2="DDI-PubMed.24692216.s13.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e1" e2="DDI-PubMed.24692216.s13.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e1" e2="DDI-PubMed.24692216.s13.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e2" e2="DDI-PubMed.24692216.s13.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e2" e2="DDI-PubMed.24692216.s13.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e2" e2="DDI-PubMed.24692216.s13.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e3" e2="DDI-PubMed.24692216.s13.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s13.e3" e2="DDI-PubMed.24692216.s13.e4" /></sentence><sentence text=" Benzylpenicillin, aspirin, and cyclo-trans-4-l-hydroxyprolyl-l-serine (JBP485) reduced cilostazol uptake in kidney slices and human organic anion transporter 3 (hOAT3)-human embryonic kidney 293 (HEK293) cells, whereas p-aminohippuric acid did not"><entity charOffset="1-17" id="DDI-PubMed.24692216.s14.e0" text="Benzylpenicillin" /><entity charOffset="19-26" id="DDI-PubMed.24692216.s14.e1" text="aspirin" /><entity charOffset="32-70" id="DDI-PubMed.24692216.s14.e2" text="cyclo-trans-4-l-hydroxyprolyl-l-serine" /><entity charOffset="72-78" id="DDI-PubMed.24692216.s14.e3" text="JBP485" /><entity charOffset="88-98" id="DDI-PubMed.24692216.s14.e4" text="cilostazol" /><entity charOffset="220-240" id="DDI-PubMed.24692216.s14.e5" text="p-aminohippuric acid" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e0" e2="DDI-PubMed.24692216.s14.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e0" e2="DDI-PubMed.24692216.s14.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e0" e2="DDI-PubMed.24692216.s14.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e0" e2="DDI-PubMed.24692216.s14.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e0" e2="DDI-PubMed.24692216.s14.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e0" e2="DDI-PubMed.24692216.s14.e5" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e1" e2="DDI-PubMed.24692216.s14.e1" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e1" e2="DDI-PubMed.24692216.s14.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e1" e2="DDI-PubMed.24692216.s14.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e1" e2="DDI-PubMed.24692216.s14.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e1" e2="DDI-PubMed.24692216.s14.e5" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e2" e2="DDI-PubMed.24692216.s14.e2" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e2" e2="DDI-PubMed.24692216.s14.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e2" e2="DDI-PubMed.24692216.s14.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e2" e2="DDI-PubMed.24692216.s14.e5" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e3" e2="DDI-PubMed.24692216.s14.e3" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e3" e2="DDI-PubMed.24692216.s14.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e3" e2="DDI-PubMed.24692216.s14.e5" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e4" e2="DDI-PubMed.24692216.s14.e4" /><pair ddi="false" e1="DDI-PubMed.24692216.s14.e4" e2="DDI-PubMed.24692216.s14.e5" /></sentence><sentence text=" Compared with the vector, hOAT3-HEK293 cells accumulated more cilostazol, whereas hOAT1-HEK293 cells did not"><entity charOffset="63-73" id="DDI-PubMed.24692216.s15.e0" text="cilostazol" /></sentence><sentence text=" OAT3 and Oat3 play a major role in cilostazol renal excretion, whereas OAT1 and Oat1 do not"><entity charOffset="36-46" id="DDI-PubMed.24692216.s16.e0" text="cilostazol" /></sentence><sentence text=" Oat3 and Cyp3a are both targets of the DDI between cilostazol and probenecid"><entity charOffset="52-62" id="DDI-PubMed.24692216.s17.e0" text="cilostazol" /><entity charOffset="67-77" id="DDI-PubMed.24692216.s17.e1" text="probenecid" /><pair ddi="false" e1="DDI-PubMed.24692216.s17.e0" e2="DDI-PubMed.24692216.s17.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s17.e0" e2="DDI-PubMed.24692216.s17.e1" /></sentence><sentence text=" Aspirin inhibits OAT3-mediated uptake of cilostazol and does not influence cilostazol metabolism"><entity charOffset="42-52" id="DDI-PubMed.24692216.s18.e0" text="cilostazol" /><entity charOffset="76-86" id="DDI-PubMed.24692216.s18.e1" text="cilostazol" /><pair ddi="false" e1="DDI-PubMed.24692216.s18.e0" e2="DDI-PubMed.24692216.s18.e0" /><pair ddi="false" e1="DDI-PubMed.24692216.s18.e0" e2="DDI-PubMed.24692216.s18.e1" /></sentence><sentence text=" " /></document>